Virbac Animal Health has launched Speed Leish K, a diagnostic test for canine leishmaniosis.
Speed Leish K detects antibodies directed against the kinesins of leishmania using a Kinesin Capture Complex (KCC), a complex of recombinant proteins with strong immunogenic power at all stages of infection. Virbac says that in trials the test has demonstrated 98.5% overall accuracy.*
Virbac Product Manager Simon Boulton MRCVS said: "Leishmaniosis presents a growing threat to UK dogs, particularly those which travel with their owners on holiday to regions where the disease is endemic.
"Speed Leish K should be used as part of the primary CaniLeish vaccination protocol in animals previously at risk of exposure to ensure only health animals are vaccinated. The test can also be used to screen for the disease in animals suspected to be infected."
Speed Leish K is presented in kits of two or six tests and can be stored for 24 months at room temperature.
The Badger Trust's legal challenge to Defra's plans for targeted badger cull pilots has failed in the High Court on all three grounds.
Whilst the RSPCA has expressed its disappointment, the British Veterinary Association and British Cattle Veterinary Association have welcomed the judgement.
BVA President Carl Padgett said: "We are pleased that the High Court has ruled Defra's policy lawful and that the pilot badger culls can now go ahead.
"The BVA and BCVA believe that the government's approach has been robust and justifiable as it is based on our current scientific knowledge.
"Bovine TB is a devastating disease and we must tackle the disease in wildlife alongside cattle controls if we are to get on top of it."
David Bowles, the RSPCA's Director of Communications, said: "We are bitterly disappointed that the UK Government in England is ploughing on with plans to kill badgers but the fight is not over yet.
"We believe culling is not a long-term, sustainable solution and will be of little help in reducing the disease - perhaps even making things worse in some areas. It will wipe out huge numbers of this much-loved species, virtually eliminating badgers from these areas, including many animals which are healthy.
"It is not as if there aren't alternatives to a cull. Vaccination could be a more effective and sustainable way of dealing with the disease, and one which does not involve killing most of the badger population in very large areas of the countryside."
A team of top equine vets is aiming to raise £125,000 for the Society for the Protection of Animals Abroad (SPANA) by travelling 3000 miles through Europe by motorbike between 22nd August and 9th September.
Sponsored by Elanco Animal Health, the seven-strong team is planning to travel through Belgium, the Netherlands, Germany, Switzerland, France, Italy, Morocco and Spain and deliver lectures to eight European and African veterinary schools in just two weeks.
Led by Professor Derek Knottenbelt from the University of Liverpool, the team also includes Professor Josh Slater from Royal Veterinary College, Dr John Burford from the University of Nottingham, Dr Caroline Hahn from the University of Edinburgh, Dr Michael Hewetson from the University of Helsinki, Ms Joanne Suthers from the University of Liverpool and Dr Edmund Hainisch from the University of Vienna. They are being supported by Jeremy Hulme, chief executive of SPANA, Nic Van Gelder, fundraising and supporter care administrator at SPANA and Cerian Stephens.
All money raised will provide SPANA with diagnostic and surgical equipment for the charity's veterinary clinics for working animals in Mali and Mauritania and for the further development of the Bamako Disabled Riding Centre in Mali.
Mike Brown, Elanco's UK and Ireland country director said: "We are delighted to be sponsoring the Vets with Horsepower European Tour which will raise vital funds for working animals in some of the world's poorest countries. This is just one of the many worthwhile initiatives we are supporting in 2012 which focus on alleviating world hunger, spearheading agricultural leadership, enhancing the human-animal bond and caring for the environment."
For further information on the Vets with Horsepower European Tour visit www.spana.org/horsepower.
Petplan has launched a new service to pay vet claims direct to practice bank accounts via BACS.
Petplan says it pays out nearly £3 million in claims each week, which is the equivalent of paying £35,000 per year to each veterinary practice in the UK. Paying practices by BACS means that the money is received faster and there is no administration required by the practice, freeing up more time for clinical work.
As part of this new service, practices also receive a detailed statement by email providing a breakdown of the client claims the payment relates to.
To register to receive claim payments by BACS, visit petplanvet.co.uk and complete an online form.
Simon Masding, Petplan's Head of Sales and Partnerships said: "Petplan has a great relationship with vet surgeries and we know in the last few years some practices have had increasing pressure on cash flow due to reduced footfall and rising costs. We are constantly looking for new, smarter ways of working to help our partners and wanted to get claim payments to vets even faster."
Petplan's Vet of the Year Brian Faulkner said: "Most people become vets because they love to work with animals, and the paperwork is merely a downside of the job. It's great to see that Petplan has reduced the time we have to dedicate to admin, meaning we can concentrate on the important things, like improving the health of Britain's pets."
For more information visit www.petplanvet.co.uk
Dechra Veterinary Products has published a range of case studies to support its new campaign focused on the diagnosis and treatment of otitis externa.
The studies have been written by Referral Dermatologist Sue Paterson MA, VetMB, DVD, DipECVD, MRCVS, RCVS European Specialist in Veterinary Dermatology and Peter Forsythe BVM&S, DVD, MRCVS, RVCS Specialist in Veterinary Dermatology.
Developed as part of the Time to Change campaign, the real-life examples feature a series of problems and solutions associated with otitis, supported by clear images and photomicrographs.
Larry King, Senior Brand Manager, Dechra Veterinary Products, said: "We have created a range of in-depth case study materials for use by vets and vet nurses which will support identification and management of otitis externa, one of the more frequent conditions seen in general practice.
"As veterinary professionals are aware, otitis is common and can be challenging to diagnose and treat. These studies address individual cases and demonstrate how the Dechra dermatology range can be used effectively.
"Topics covered in the case studies include the types of otitis presented by each animal, how individual organisms were identified using cytology and how long treatment was continued."
The case studies, which feature Malassezia, staphylococcal and Proteus infections, also discuss the underlying causes and steps taken after treatment with Canaural and various ear cleaners.
The Time to Change campaign has been launched to support a best practice approach to otitis which includes the identification of the organisms causing infection through cytology, support the selection of the correct treatment and assist with educating clients on how to apply and use products correctly.
For further information visit www.dechra.com/timetochange. The website also highlights the benefits of Dechra Veterinary Products' range of topical treatments and ear flushes, including Canaural, CleanAural, CerumAurual, TrizAural and MalAceticAural.
Virbac Animal Health is calling on practices to prepare for Canine Prostate Awareness Month (CPAM), being held by the company in November to highlight the prevalence of the disease and to encourage owners and practices to test for it.
Last year, 400 practices sign up to support the event, and the company says that feedback from many taking part confirmed a significant lack of understanding among clients as to the risk of prostate disease in dogs.
Canine Prostate Awareness Month is timed to coincide with 'Movember', when thousands of men grow moustaches to raise funds for male prostate and testicular cancer. During the month, Virbac is providing promotional materials including dog leads; educational and display materials and a press release for local media.
Chris Geddes MRCVS, Virbac Product Manager, said: "With more than 80% of entire male dogs over the age of five suffering from Benign Prostatic Hyperplasia (BPH)¹, we wanted to give practices a reason to highlight the risk and encourage owners to test for it. Timing CPAM to coincide with Movember seemed a good way to interest dog owners at a time when some might be considering the state of their own prostate.
"The support we received last year confirmed that it was a topic which practices were keen to discuss with dog owners so we're already planning to make the initiative even bigger and better this year."
Stephen Bamber, Principal at participating practice Warwickshire-based Avonvale Vets, added: "CPAM was an attractive campaign as it was a bit different. It offered the opportunity to see some of our older patients with other, less obvious pathologies. Non-symptomatic testicular tumours in particular surfaced in the checks we did. Clients generally had little idea about dogs' prostates so it gave us a good platform to discuss prostate disease with them."
Virbac has introduced OdelisTM CPSE, the first ELISA test to screen for, diagnose and monitor BPH, available from three UK diagnostic laboratories. The company says it's a cost-effective, precise and reliable alternative to rectal palpation. Virbac also offers Ypozane, a tablet treatment for BPH which takes effect within a week and lasts for up to six months.
Chris added: "BPH is an unpleasant condition occurring in nearly all entire dogs as they get older, but one which is entirely treatable. We hope that, by running our Prostate Awareness Campaign at a time when the media spotlight is already on the dangers of prostate cancer in men, we can help spread the message that owners should be monitoring older dogs for signs of prostate disease."
For further information on the Prostate Awareness Campaign, email cpam@virbac.co.uk; contact your Virbac Territory Manager or contact the company direct on 01359 243243.
References
The Webinar Vet has released the results of a survey which shows that its members are far exceeding their 35 hour CPD target.
Launched just over two years ago, The Webinar Vet was the first company in the UK to specialise in web-based CPD for vets and now has nearly 1000 members from around the globe.
The Webinar Vet founder Anthony Chadwick MRCVS said: "Our members average over 60 hours of online CPD per year. Indeed several members are exceeding 100 hours a year including workshops, and some have even recorded over 200 hours of total CPD!
"There will always be a need for workshop CPD, but most vets and VNs can get the majority of the updates and information they need online. However we believe that in many cases it's not a simple swap - the convenience of online CPD means that many vets and VNs are earning more total hours, which can only be a good thing for the profession.
"Many vets and VNs are juggling busy family lives with work in practice, and the convenience of viewing and participating in webinars from your own home or in a practice lunch break is both cost and time saving, not to mention the reduction in carbon footprint."
Boehringer Ingelheim Vetmedica has launched a new Canikur Pro website - www.canikurpro.co.uk - to provide pet owners with advice on digestive upset and offer a quick reference guide to using Canikur Pro.
The site offers information about the common causes of digestive upset, including dietary indiscretions, stress due to a change in circumstances and underlying gut problems.
The site also contains information about how Canikur Pro works, how to give the product and where to buy it, plus tips for supporting the recovery of a dog's gut health such as providing a constant supply of fresh water, offering a bland diet and providing access to outside areas to reduce accidents.
In addition, the site contains a 'veterinary only' area where veterinary professionals can download client materials.
Norbrook Laboratories Ltd has announced the launch of Pestigon, a fipronil spot-on solution for cats and dogs.
Rebekah Dudek, Norbrook Veterinary Advisor said: "Pestigon offers a fast-acting and long-lasting treatment for cats and dogs suffering from flea and tick irritations. The new product will have an immediate effect against flea infestations and will kill ticks within the first 24 - 48 hours of application. Fipronil is a tried and tested ingredient with proven efficacy against fleas and ticks. Pestigon provides a fast-acting treatment whose effectiveness will continue against new infestations of fleas for up to 58 days on dogs and 37 days in cats and against ticks for up to 30 days in dogs and 21 days in cats."
To coincide with the launch of Pestigon, Norbrook has rebranded its Permaguard household spray which is now available with 12 month protection.
Rebekah said: "The total life cycle of a flea can last from a couple of weeks to several months. Only adult fleas live on cats or dogs while the eggs, larvae and pupae can be found around the house in carpet, furniture, bedding etc for up to a year or more. It is therefore crucial that pet owners treat the household to break the life cycle and ensure effective and lasting flea control. Pestigon and Permaguard together will give pet owners a complete treatment."
Pestigon range offers 5 alternatives for cats and dogs depending on size and comes with colour co-ordinated pipettes available in packs of 3, 6 and 24 to allow for single or multiple pipette dispensing.
Norbrook's Small Animal Brand Manager, Michelle Jones said: "Pestigon is licensed as a POM-V product and will be sold exclusively through veterinary practices. We have produced a range of marketing materials for veterinary practices to help them offer support on flea and tick control in the home to their customers."
Orders for Pestigon and Permaguard can be placed through your Norbrook representative now.
The Kennel Club is hosting its second Puppy Awareness Week to help improve the health and lives of dogs around the UK, and is seeking assistance from the veterinary profession.
Puppy Awareness Week is taking place from 8th - 14th September and aims to help people find a healthy, happy puppy that is right for their lifestyle, whilst raising awareness about the plight of puppies and breeding bitches born into cruel puppy farms.
To help, veterinary surgeons and nurses are being asked to join in the week, putting up posters and literature in client waiting areas, and selling Puppy Awareness Week badges for £2, which will go to the Kennel Club Charitable Trust.
Caroline Kisko, Kennel Club Secretary said: "It is vitally important that we spread the word about buying puppies responsibly. At veterinary surgeries there is a captive audience of animal lovers and we can't think of anyone better to communicate with. Not only are a vet's clients animal lovers and as such, potential new dog owners, but they may also make great champions of the cause, spreading the message about buying a puppy responsibly further afield.
"Sadly, we are seeing tens of thousands of puppies born each year suffer as puppy farms churn out litter after litter of undernourished and badly cared for puppies, and then selling them on to unsuspecting owners through pet shops, newspaper ads, online adverts and various other means. With help from veterinary practices we want to provide information throughout Puppy Awareness Week to help people understand how to buy a healthy, happy puppy, and to raise money for the Kennel Club Charitable Trust, which supports charities and organisations that are making dogs' lives better."
To get involved in Puppy Awareness Week and receive literature and Puppy Awareness badges, contact the Kennel Club press office at press.office@thekennelclub.org.uk.
Puppy Awareness Week will kick off at Pup Aid on September 8th in Primrose Hill, London and will run until 14th September. To find out more, visit www.thekennelclub.org.uk/paw.
Organisers of the Vet Charity Challenge are calling for more people to take part in the event, to join the 100 that are already set to walk, run, cycle, kayak and orienteer around the grounds of the Royal Agricultural College in Cirencester on On 15th September.
Gavin Mitchell from BCF Technology said: "We have entered two teams and already have a £100 bet on which of our teams will gain the most points on the day. This rivalry has certainly had a positive influence on the amount of training we are all doing to prepare for the challenge. The teams are out cycling after work and off for runs during lunchtimes."
Gavin added: "We are keen to ensure we beat the other teams such as those from Vets Now, and Clent Hills Vet Group. No pressure!"
Teams are also starting to gather sponsorship for the three chosen charities of SPANA, Hounds for Heroes and Pet Blood Bank. The team that raises the most amount will win a day's in-practice imaging training with the BCF in-house vet Kimberly Palgrave, BS BVM&S GPCert(DI) MRCVS.
Andrew Groom from Kruuse said: "This is a great focus to help get fit over the summer months, build team spirit within a practice and enhance a practice's profile locally, as well as raising money for some great causes. There is still room for a few more teams, so we urge practices to not wait any longer and sign a team up now."
For more information visit www.vetcharitychallenge.co.uk, call 01727 859 259 or find it at www.facebook.com/vetcharitychallenge
Ceva Animal Health has produced a leaflet to help horse owners understand the cause, diagnosis and management of equine back pain.
The company says the management of back pain in the horse can be a particular challenge to vets and a source of frustration for owners. Early diagnosis is likely to be associated with a more favourable outcome but it's important to ensure that other causes of pain and poor performance such as lameness, are not contributing to the horse's clinical signs.
'Understanding back pain' explains the anatomy of the back, as well as the clinical signs of back pain, and how it is diagnosed, including the treatment options and the general prognosis. Copies of the new leaflet are available, free of charge, from your Ceva sales representative. Leaflets on 'Understanding bone spavin', 'Understanding navicular disease', 'Understanding sacroiliac disease' and 'Equidronate discharge instructions', are also available.
For further information contact your local Ceva representative or Ceva Animal Health Ltd, Unit 3, Anglo Office Park, White Lion Road, Amersham, Bucks, HP7 9FB, Telephone +44 (0) 1494 781510.
Pfizer Animal Health's Equine Herpes Virus (EHV) vaccine (Duvaxyn EHV 1,4) has been rebranded Equip EHV 1,4).
Pfizer says that EHV is carried by most horses in the UK1 and can cause respiratory disease, abortion and more rarely neurological disease. However, it is the more common sub-clinical infections that pose the most apparent issue for the competition client, with the associated loss of performance and the potential effect on the health of the whole yard.
Once infected with EHV, a horse can harbour the virus throughout its life and potentially shed the disease to other animals without showing any outward signs. According to the company, vaccinating helps to minimise the severity of the disease itself and importantly, can also help to reduce the amount of infective virus that is shed to other in-contact horses.
Equip EHV 1,4 is given as a primary course of two vaccinations, 4-6 weeks apart followed by a single dose every six months. It can also be used as an aid in the control of EHV-1 abortion - pregnant mares should be vaccinated with a single dose during each of the 5th, 7th and 9th months of pregnancy.
For further information on Pfizer's EHV campaign, to obtain literature for your practice or to book a talk for your clients contact your Pfizer Account Manager or Pfizer Animal Health, Walton Oaks, Tadworth, Surrey KT20 7NS.
Reference
1. Eddington et al. Equine Vet. J. 1994; 26 (2): 140-142.
Bulk milk surveillance for stomach worm exposure in dairy cows has found high levels in 68% of herds, with "probable sub-clinical effects on health and production", according to Pfizer Animal Health.
Between September 2011 and March this year, 449 milk samples submitted by dairy vets and SQP animal health advisers were analysed independently for Pfizer VPS.
Pfizer VPS vet Andrew Montgomery says that stomach worm (Ostertagia ostertagi) is the species identified most often in dairy cows1,2. and known to suppress appetite3: "Numerous trials have found a yield response to worming treatment, typically in the region of 1kg/cow/day."4
"At 25p/litre, this would be worth £76/cow over a 305-day lactation, or about £16,500/year in a typical 200-cow herd. Some trials have also identified improvements in reproductive performance although this remains to be proven absolutely."4
When test results indicate that worming is justified, Andrew recommends a moxidectin pour on treatment in the late dry period to maximise the gain over the highest yielding, early part of lactation.
The bulk milk surveillance programme is ongoing, and free Pfizer test kits are available from participating VPS animal medicine suppliers and veterinary practices.
The RCVS welcomed 15 veterinary surgeons who passed the RCVS Statutory Examination for Membership with a registration ceremony held on Monday at Belgravia House.
The RCVS Statutory Examination for Membership is open to veterinary surgeons with a veterinary degree gained outside the UK that is not recognised by the RCVS, and who therefore cannot join the RCVS Register. Candidates for the exam must also score at least 7.0 in the academic International English Language Testing System (IELTS) test, which is comparable to requirements for entry to UK veterinary degrees and those of other professional regulators.
RCVS President Jacqui Molyneux said: "Your success is remarkable - especially for those whose first language is not English. The veterinary profession in the UK is small and welcoming, and you will find valuable support offered by the different members of the veterinary team as well as from professional organisations."
Registering at the ceremony was Mr Vahidreza Ardani, who qualified from the Islamic Azad University in Iran, where he practised for ten years as a large animal vet. He said: "It took me nearly three years of study to prepare for the IELTS [English language] exam. I have also been seeing practice here for the past two and a half years, including at the small animal hospital at the University of Glasgow. I hope now to find work at a small animal practice."
Ms Olga Woolmer, who qualified from Perm State Agricultural Academy, Russia, also registered. Olga saw practice in several UK small animal and equine practices as preparation for the exam, whilst also working as an animal technician. She said: "I'm really grateful to all the practices that let me see practice. In particular, Burghley Veterinary Centre at Stamford helped me a lot in learning about what veterinary clients in the UK expect and how to sound confident when I give advice - which ultimately is best for the patient. It's great that I will soon be able again to do the work that I've trained so hard for."
Vetoquinol has published a waiting room poster which highlights canine pain, to support Cimalgex.
Robert Simpson, Product Manager for Cimalgex said: "This poster aims to highlight that pain may not be obvious to pet owners and that signs which the owner may believe to be age related, for example stiffness, may actually be behavioural signs of pain. The most common sign of pain is a change in behaviour and so this is an area which we believe needs to be highlighted to the pet owner1.
"This new poster uses a strong image to catch the pet owner's attention which, when combined with its simple message, will prompt the pet owner to ask for further information from the veterinary practice regarding pain to ensure the overall wellbeing of their pet. This poster complements our client leaflet in helping the veterinary practice to assist the pet owner to spot signs of pain which may not be very obvious."
To find out more or to request a waiting room poster for your practice please contact your Vetoquinol Territory Manager or call 01280 825424.
1. Hellyer P. et al. AAHA/AAFP Pain Management guidelines for Dogs and Cats. J. AM Anim Hosp Assoc 2007; 43: 235-248.
A research project funded by equine charity The Horse Trust has found that lameness is the most common reason for euthanasing a geriatric horse.
According to the charity, this research is the first in the UK to provide data on the causes of death in geriatric horses. Although post-mortem studies have provided some data regarding causes of death, "old age" was previously reported as a common reason for the euthanasia of adult horses.
The research was carried out by Joanne Ireland at the University of Liverpool and led by Dr Gina Pinchbeck. Ireland surveyed horse owners living in the North-West and Midlands areas of England and North Wales who have a horse aged 15 years or older. 918 owners of geriatric horses were followed in a cohort study and 118 mortalities were reported during the 18 month follow-up period, of which 111 were euthanased.
The researchers found that 24% of horses were euthanased due to lameness; an additional 12% were euthanased due to laminitis - a common cause of lameness. After lameness, colic was the next most common cause of euthanasia, with 21% of owners citing this as the main reason.
In an earlier stage of the project, the researchers had found that half the geriatric horses surveyed suffered from lameness, but only 24% of owners reported the problem.
Dr Pinchbeck said: "Although lameness is common in older horses, this is the first study to quantify its contribution to their mortality.
"Owners are often missing the early signs of lameness in their horse, which means the condition isn't being managed and may deteriorate faster."
Dr Pinchbeck said it would be useful to carry out further research into lameness in geriatric horses to find out the main causes of lameness and how these may be prevented or treated.
The research team also found that half of the horses euthanased were suffering from concurrent health problems and these influenced the owner's decision to euthanase in 43% of cases. The most frequently reported additional health problems were musculoskeletal problems, such as arthritis.
The mortality rate among the horses surveyed was 11 per 100 horse-years at risk, meaning that if 100 geriatric horses were followed for a year, an average of 11 would die. The mortality rate for horses over 30 years of age was over five times the rate than in horses aged 15 - 19 years.
Jeanette Allen, Chief Executive of The Horse Trust, said the data provided by this research is likely to provide useful information for both horse owners and vets to enable them to improve the welfare of older horses. She said: "As there are a significant number of geriatric horses in the UK, it is vital that we understand more about the health problems that affect them. We hope that more owners of older horses will give their horse an annual health-check to enable the horse to have a longer, healthier life."
The research was published in the September 2011 issue of Preventive Veterinary Medicine.
Vetoquinol has announced the launch of Equistro Flexadin UCII, an equine joint supplement.
Equistro Flexadin UCII contains a new ingredient, UC-II, which the company claims is one of the most effective and influential ingredients available that aids and supports healthy joint function.
To celebrate the launch of Flexadin UCII Vetoquinol is offering a £10 money off voucher available through purchases of Horse & Hound magazine starting from November 10th.
Caitríona Mullin, Equine Product Manager at Vetoquinol UK Ltd said: "We are very excited about the launch of Flexadin UCII in the UK and Ireland, we have already received excellent feedback from our German and French colleagues. Flexadin UCII is a product that will further enhance our premium range of equine supplements formulated specifically for the performance horse."
Pet owners who believe in preventative healthcare have maintained or increased the money they spend on their pets this year, and 84% visited their vet at least once in 2010, up from 78% in 2007, according to a survey commissioned by the National Office of Animal Health.
According to the survey of 1000 owners carried out by Noesis, 44% of 'preventers' increased their spending on their pets in the last year with only a very small number (5%) decreasing it. There has also been a significant increase in the number of dogs insured by this group since 2007, which now stands at 55% compared to 41% in 2007.
The research covered both 'preventer' and 'non-preventer pet owners and sought to understand: awareness of preventative medicine in cats and dogs; how the decision is made as to what areas of preventative medicine are important and which to adopt; what types of preventative medicine are carried out and the reasons and frequency of this behaviour as well as the sources of information.
In addition to visiting their vet more frequently and spending more on their pets, preventers also visited a pet shop significantly more often than non-preventers with nearly two thirds (61%) of preventers visiting at least once a month compared to 36% of non-preventers, a figure that has decreased from 43% in 2007.
Looking at specific preventative treatments, attitudes to vaccination had not changed between the 2007 and 2010 surveys, with preventers believing that being a responsible pet owner means regularly vaccinating your pet, while non-preventers did not believe vaccination was relevant to their situation. This points to a clear need to educate non-preventers to break habits that have sometimes been handed down from generation to generation.
Most owners from both groups had used a flea treatment on their pets in the past two years although 68% of preventers were much more proactive in their usage of flea products compared to only 40% of non-preventers. Cats (80%) are more likely to have been treated than dogs (69%) among both groups of owners although flea treatment of cats has significantly decreased among non-preventers since 2007.
Use of wormers was also in decline. Although 86% of preventers worm proactively as part of a healthcare routine for their pet, this figure has decreased from 96% in 2007. Non preventers chose not to worm because they did not see the need, citing reasons such as their pet being fit and well or not going outdoors. Likewise, although preventers are more likely than non-preventers to be aware of the zoonotic implications of pet parasites, this awareness had decreased since 2007 pointing to the need for more work to be done on this aspect of pet health. On a more upbeat note, those that were worming proactively wormed their pets more frequently with 50% worming at least every three months in 2010 which was significantly more than compared to 41% in 2007.
When asked where they obtained general healthcare advice, the vet was the most frequently cited source of information with 84% of preventers and 58% of non-preventers referencing their vet. The internet is an increasingly important information channel for non-preventers with almost a third (31%) citing it as their source for pet healthcare advice, an increase from 25% in 2007.
There was huge interest from both groups (87% of preventers and 79% of non-preventers) in using a dedicated website such as NOAH's http://www.pethealthinfo.org.uk/ which 10% of the pet owners surveyed had heard of. It was welcomed for providing easy access, immediate, independent advice and being written by veterinary experts.
Commenting on the research, Phil Sketchley, chief executive of NOAH said: "We commissioned the original piece of research in 2007 to understand the differences between both groups of pet owners and understand where they sourced their information in order to influence the pet healthcare habits of the non-preventers in particular. The importance of the internet as a source of information proved that our strategy to launch http://www.pethealthinfo.org.uk/ was on target and the latest survey shows that this channel is increasingly important, particularly among non-preventers.
"The 2011 survey also reveals some positive insights into the preventative healthcare habits of those pet owners that we termed preventers. This group are more likely to insure their pet (45% vs 12%), go to the vet at least once a year (84% vs 30%) and visit a pet shop at least on a monthly basis (61% vs 36%). And, as a final piece of good news, this group have increased their total spend on their pets in the last year and very few members of either group had decreased their spend.
"Whilst all pet owners consider themselves responsible clearly some do not see regular preventative healthcare as part of that responsibility. So there remains a clear need to educate pet owners, particularly the non-preventers, to change some of the patterns of behaviour and complacency regarding their pet's health that have become entrenched and seem to have been influenced by friends and family."
The Veterinary Marketing Association is running a free seminar on Thursday 24th November from 5-7pm for any delegates of the London Vet Show, or those in the vicinity, that feel they'd like to learn about the principles of marketing.
The VMA says that in today's competitive environment, the key to success for a veterinary business is often making oneself heard and standing out above the competition, but questions how many vets are taught any marketing at college or whether marketing is something that most vets just pick up over time?
The VMA's Principles of Marketing seminar will aim to address the basics in marketing, with an emphasis on the veterinary sector. It's taking place at the Hilton Hotel, London Olympia, a few minutes walk from the show.
The VMA has enlisted the services of Paul Fifield (Visiting Professor in Marketing Strategy at the Southampton University School of Management) to deliver the seminar.
This event is open to anyone and entry is free. As spaces are limited to a maximum of 60, registration is strongly advisable. For more information, or to register, please visit the VMA's website - http://www.vma.org.uk/.
The seminar will be followed by a free buffet and time for questions.
Boehringer Ingelheim Vetmedica and the Feline Advisory Bureau (FAB) have launched Spot The Signs, a campaign designed to help owners spot the signs of painful, age-related conditions in cats, such as arthritis.
According to the company, which makes Metacam, 46% of cats are now classed as 'mature and older', and 87% of vets have treated cats aged 22 or more. Yet a survey of 3000 cat owners found that 75% would not recognise the signs of chronic pain in their cat. And despite 50% of owners believing that cats suffer pain the same way as humans, 78% of cats had never been taken to the vet for an old age check up.
99% of 77 veterinary surgeons surveyed agreed that chronic pain often goes unnoticed and that signs of pain can be confused with cats simply getting old. When shown a list of common signs of long term pain in cats, 65% of owners recognised at least one of these signs in their own cat.
Claire Bessant, leading feline author and CEO of FAB, said: "In a recent study, 65% of cats aged 12 and above showed evidence of arthritis when X-rayed. The survey also showed that a large proportion of cats do show signs that may be caused by chronic pain, including becoming withdrawn, reduced grooming and reduced activity, but these were not attributed to pain by the owners. Arthritis has only just been recognised by the veterinary profession as a major problem in cats and so it is not surprising that 80% of cat owners do not realise that their cats can develop this painful condition."
Most owners understand that arthritis can cause significant pain and discomfort, and 93% said they would feel guilty if their cat was in pain and they hadn't realised. 65% of Brits see their cat as member of the family, with 20% saying their cat is like a child to them.
The Spot the Signs campaign is being 'fronted' by Jess the Cat, Postman Pat's sidekick, with expert support from a panel of cat medicine and behaviour specialists including leading feline author Claire Bessant and VetSurgeon.org / VetNurse.co.uk blogger, Pete Wedderburn MRCVS. The campaign includes support materials for veterinary practices and a facebook page.
Claire Fowler, Boehringer Ingelheim, said: "Despite a steady increase in the number of cases of arthritis and chronic pain in cats being diagnosed, our research shows awareness amongst cat owners of how to look for pain in their cats remains surprisingly low, despite 86% saying they would want their vet to let them know if their cat might be in pain. For many owners, spotting the signs of pain in their cat can be difficult, so we have set out to educate cat owners about what to look for and to encourage them to consult their vet or vet nurse if they are concerned."
Following the announcement from the Dogs Trust that the number of stray and abandoned dogs has reached an 11 year high, Pedigree has launched it's fourth annual Adoption Drive.
The campaign, which seeks to raise awareness and funds for the thousands of strayed and abandoned dogs in the UK, comes at a time when recent statistics put the number of dogs being picked up by local authorities in the last year at 126,176 - the worst in over a decade.
Since its launch, The Pedigree Adoption Drive has raised over £1million for rescue centres up and down the country who are working tirelessly to find new and loving homes for abandoned dogs. Last year alone, grants of almost a quarter of a million pounds were distributed to 34 rescue homes and went towards funding the vital refurbishment of dilapidated kennel blocks, desperately needed veterinary facilities and the supply of essential surgical equipment.
TV presenter and wildlife vet Steve Leonard, who is supporting this year's campaign, said: "Rescue centres across the country are at capacity due to the overwhelming number of stray and abandoned dogs in Britain - a number which is sadly still on the rise. We need to work together to make people aware of this issue and educate them about both the benefits and commitment involved in owning a dog. The funds and support generated by this campaign, help to give abandoned dogs everywhere a second chance at the loving homes they deserve."
During the campaign, Pedigree is sponsoring Pete Wedderburn's blog on www.vetsurgeon.org
Fiona Knight, a Customer Care Manager from the Woodcroft Veterinary Group in Cheshire, has won the 'Petplan Insurance Advisor Award 2011'.
The award, announced at the British Veterinary Nursing Congress in Kettering, recognises the hard work and dedication that Petplan Insurance Advisors do to highlight the importance of insurance to pet owners.
Fiona said: "It was such a shock to actually win the award, I'm very pleased!. All the finalists, including me, have worked incredibly hard to carry on promoting something we feel so strongly about. It's not something we can do on our own which is why I am so grateful for the dedication and support from my team at the practice.
"The Petplan PIA is such a great scheme as it helps increase the awareness of pet insurance, and really helps owners have financial security and their pets get the best treatment should anything happen."
The finalists were judged by Petplan Business Developers Lisa Allen and Spencer Jones.
Spencer said: "All three finalists have worked extremely hard to educate pet owners about pet insurance so that they are able to give their customers informed and up-to-date advice, however Fiona's commitment and dedication really stood out and she is a very deserving winner."
As part of her award Fiona receives a 16GB Ipad2 with WiFi, worth £399. The other finalists were Harriet Goulden, veterinary nurse at the Feldon Veterinary Centre in Leicestershire, and Alison Sawyer, receptionist at Medivet in Watford.
For information on how to become a PIA contact Vetline on 0800 316 8800 or alternatively log onto www.petplanpia.co.uk.
Animalcare Ltd has launched Tilmodil (tilmicosin 300mg/ml solution for injection), a semi-synthetic macrolide antibiotic licensed for pneumonia in cattle and sheep, foul in the foot in cattle, and footrot and mastitis in sheep.
According to the company, Tilmicosin is fast-acting1, long-acting2 and highly effective against the major Gram-ve bovine respiratory pathogens.2,3 In addition, the company says tissue penetration is excellent.1 In calves a single SC injection at 10mg/kg bw results in lung concentrations exceeding the MIC90 of Mannheimia haemolytica for 72 hours.2
Animalcare says that pooled data from greater than 6000 cattle has confirmed the effectiveness of tilmicosin in the treatment of bovine respiratory disease (BRD) in well-controlled, randomised field studies. Tilmodil treatment has been proven equally effective compared to antibiotics, such as florfenicol, marbofloxacin and danofloxacin.
A recent report by the Farm Animal Welfare Council estimates that three million of the national sheep flock are lame at any one time. It is estimated that footrot is responsible for greater than 90% of lameness and is present in 97% of flocks. Tilmicosin has good activity against the key Gram-ve pathogens2 and has been successfully used in the treatment of footrot.4
Tilmodil has been developed for animal use only and is administered by veterinary surgeons only. Dosage is 1ml per 30kg bw for respiratory disease and mastitis in sheep and 0.5ml per 30kg bw for interdigital necrobacillosis (foul in the foot/footrot/bovine pododermatitis).
Tilmodil is administered as a single, low volume subcutaneous (SC) injection dose and presented in 50ml multi-dose vials.
1. Apley M., Antimicrobial therapy of Bovine Respiratory Disease.Veterinary Clinics of North America.Food Animal Practice (1997) 13,3:159-5622. Tilmodil SPC3. Giguere S et al .,Antimicrobial therapy in Veterinary Medicine.4th edition 2006.Chp.12,2014. Winter A., Lameness in sheep. 2. Treatment and control. In Practice (2004),3, 130-139.
Woodley Equipment Company Ltd has been appointed as the UK and European master veterinary distributor for the Mythic 18 Vet haematology analyser manufactured by Orphee-Medical, Switzerland.
The Mythic 18 Vet is a fully automated, 18 parameter haematology analyser dedicated for veterinary applications. Woodley says it delivers the ultimate technology in haematology, requires little maintenance and benefits from low reagent consumption. It's quick and easy to use with touch screen technology and can produce accurate results in just 60 seconds for over 10 different species using a small sample volume.
For more information, visit: www.woodleyequipment.com, email: sales@woodleyequipment.com or call: +44(0)1204 669033